EP 4125952 A1 20230208 - PLATELET LYSATE FOAM FOR CELL CULTURE, CELL THERAPY AND TISSULAR REGENERATION AND METHOD FOR OBTAINING SAME
Title (en)
PLATELET LYSATE FOAM FOR CELL CULTURE, CELL THERAPY AND TISSULAR REGENERATION AND METHOD FOR OBTAINING SAME
Title (de)
BLUTPLÄTTCHENLYSATSCHAUM FÜR ZELLKULTUR, ZELLTHERAPIE UND GEWEBEREGENERATION SOWIE VERFAHREN ZUR HERSTELLUNG DAVON
Title (fr)
MOUSSE DE LYSAT PLAQUETTAIRE POUR LA CULTURE CELLULAIRE, LA THÉRAPIE CELLULAIRE ET LA RÉGÉNÉRATION TISSULAIRE ET PROCÉDÉ D'OBTENTION
Publication
Application
Priority
- FR 2002800 A 20200323
- FR 2021050427 W 20210315
Abstract (en)
[origin: CA3176724A1] The present invention relates to a platelet lysate foam obtained from a blood derivative (allogenic or autologous) which conserves the biological properties of the platelet lysates and has optimum properties, in particular mechanical properties but also conservation properties, which allow its marketing and facilitate its handling. The present invention also relates to the use of a platelet lysate foam for therapeutic purposes, cell culture and cell therapy. The present invention also relates to a method for obtaining a platelet lysate foam by a method of drying in a supercritical CO2 atmosphere.
IPC 8 full level
A61K 35/19 (2006.01); A61K 47/46 (2006.01); A61L 27/36 (2006.01); A61P 1/02 (2006.01); A61P 17/02 (2006.01); A61P 19/08 (2006.01); A61P 27/02 (2006.01); C12N 5/00 (2006.01)
CPC (source: EP US)
A61K 9/122 (2013.01 - US); A61K 31/195 (2013.01 - US); A61K 33/06 (2013.01 - US); A61K 35/19 (2013.01 - EP US); A61K 38/1808 (2013.01 - US); A61K 38/1825 (2013.01 - US); A61K 38/1841 (2013.01 - US); A61K 38/1858 (2013.01 - US); A61K 38/1866 (2013.01 - US); A61K 38/30 (2013.01 - US); A61K 47/42 (2013.01 - US); A61L 27/3616 (2013.01 - EP US); A61L 27/3691 (2013.01 - EP); A61L 27/56 (2013.01 - US); A61P 1/02 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 19/08 (2018.01 - EP); A61P 27/02 (2018.01 - EP); C12N 5/0068 (2013.01 - EP); A61L 2430/02 (2013.01 - US); A61L 2430/12 (2013.01 - US); C12N 2501/11 (2013.01 - EP); C12N 2501/115 (2013.01 - EP); C12N 2501/135 (2013.01 - EP); C12N 2501/15 (2013.01 - EP); C12N 2501/165 (2013.01 - EP); C12N 2502/115 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
FR 3108253 A1 20210924; FR 3108253 B1 20231027; CA 3176724 A1 20210930; EP 4125952 A1 20230208; US 2023119928 A1 20230420; WO 2021191525 A1 20210930
DOCDB simple family (application)
FR 2002800 A 20200323; CA 3176724 A 20210315; EP 21716804 A 20210315; FR 2021050427 W 20210315; US 202117906989 A 20210315